First paediatric abacavir/dolutegravir/lamivudine 60mg/5mg/30mg dispersible tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequal
Zhejiang Apeloa Kangyu’s nirmatrelvir + ritonavir tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
Vaccines prequalification prioritity list 2024-2026
V
For more information click here
Registration is open for Joint UNICEF-UNFPA-WHO Meeting with Manufacturers and Suppliers
ID
IVD
IS
M
V
VCP
for more information click here
10th Invitation to manufacturers of reproductive health products to submit an expression of interest (EOI) for product evaluation to the WHO Prequalification Team: medicines
M
Addition:
Under section: 9. Antifibrinolytics
22nd Invitation for Expression of Interest (EOI) to manufacturers of antimalarial medicines published
M
New Invitation for Expression of Interest (EOI) to manufacturers of antimalarial medicines published
Addition: